Industries > Pharma > Clinical Trial Supplies Market Report 2023-2033
Back to Pharma Reports
Clinical Trial Supplies Market Report 2023-2033

Clinical Trial Supplies Market Report 2023-2033

Forecasts by Location (Offshore Clinical Site, Domestic Clinical Site), by Type (Small Molecule Products, Biologic Products, Medical Devices), by Services (Manufacturing (IMPs and INDs, Placebos, Assays and Test Kits, Others), Logistics & Distribution (Cold Chain Distribution, Non-cold Chain), Storage & Retention, Packaging and Labelling, Comparator Sourcing, Other), by Therapeutic Areas (Oncology, CNS and Mental Disorders, Cardiovascular Disease (CVD), Infectious Disease, Immunology Disease, Blood Disorders, Metabolic Disorders, Digestive Disorders, Other), by Phase (Phase-I, Phase-II, Phase-III, Phase-IV), by End-user (Contract Research Organisations, Pharmaceutical and Biotechnology Companies, Medical Device Companies, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 31 January 2023
PAGES: 423
PRODUCT CODE: PHA1229
SUBMARKET: Contract Services

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1229 Categories: , Tags: , , , , , , , , , , , ,

The Clinical Trial Supplies Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Demand for Clinical Trial Outsourcing is driving the Demand for Clinical Trial Supplies Market
Downsizing and cost-cutting are important factors for large and mid-size pharmaceutical companies to outsource clinical trials, as CRO expertise in a specific therapeutic in a market where the company lacks experience with regulatory processes, operational expertise, and the ability to use manpower for other activities at the time of increasing workload. Furthermore, due to the increasing process complexity and cost of clinical studies, pharmaceutical manufacturers have been forced to outsource clinical trial supplies and supply them to research sites for reducing cost and time. Clinical supply firms are concentrating on data sharing to assist them build a solid supply chain for clinical consumables during clinical trials. This factor will have a favourable impact on the revenue growth of the clinical trial supplies market throughout the forecast period.

Unavailability of Storage Facilities in across Multiple Nations May Hamper the Expansion Clinical Trial Supplies Market
Certain clinical materials must be stored under specific climatic conditions, and such facilities are critical before conducting clinical studies. However, in countries such as Mexico, Brazil, and others, lack of clinical supply storage facilities and infrastructure may impede market acceptance of clinical trial supplies services. It is critical, for example, to determine early on if important components of the cold chain must be held in controlled temperature facilities if things are stored. Transportation of clinical supplies from cold storage to clinical sites is difficult, which is projected to limit revenue growth in this market to some extent.

What Questions Should You Ask before Buying a Market Research Report?
• How is the clinical trial supplies market evolving?
• What is driving and restraining the clinical trial supplies market?
• How will each clinical trial supplies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each clinical trial supplies submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading clinical trial supplies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the clinical trial supplies projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of clinical trial supplies projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the clinical trial supplies market?
• Where is the clinical trial supplies market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial supplies market today, and over the next 10 years:
• Our 423-page report provides 187 tables and 272 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trial supplies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial supplies prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Location
• Offshore Clinical Site
• Domestic Clinical Site

Type
• Small Molecule Products
• Biologic Products
• Medical Devices

Services
• Manufacturing
– IMPs and INDs
– Placebos
– Assays and Testkits
– Others
• Logistics & Distribution
– Cold Chain Distribution
– Non-cold Chain
• Storage & Retention
• Packaging and Labeling
• Comparator Sourcing
• Other CTS Services

Therapeutic Areas
• Oncology
• CNS and Mental Disorders
• Cardiovascular Disease (CVD)
• Infectious Disease
• Immunology Disease
• Blood Disorders
• Metabolic Disorders
• Digestive Disorders
• Other Therapeutic Areas

Phase
• Phase-I
• Phase-II
• Phase-III
• Phase-IV

End-User
• Contract Research Organizations
• Pharmaceutical and Biotechnology Companies
• Medical Device Companies
• Other End-Users

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 23 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• South Africa
• Saudi Arabia
• Turkey
• UAE
• Rest of MEA

Clinical Trial Supplies Market Report 2023-2033
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Clinical Trial Supplies Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• ADAllen Pharma
• AmerisourceBergen Corporation
• Ancillare
• Biocair
• Catalent, Inc.
• Clinigen Group plc
• Coghlan Group
• COREX Logistics
• DHL
• Durbin
• Endpoint Clinical
• Eurofins Scientific SE
• Inizio (UDG Healthcare plc)
• IQVIA Inc.
• KLIFO
• Liveo Research
• Lonza
• Marken (A UPS Company)
• Movianto
• Myonex
• N-SIDE
• Parexel
• PCI Pharma Services
• Piramal Pharma Solutions
• Recipharm AB
• Rubicon Research Pvt S.A.
• Seveillar Clinical Supplies Services
• Sharp Corporation
• SIRO Clinpharm
• Thermo Fisher Scientific Inc.

Overall world revenue for Clinical Trial Supplies Market, 2023 to 2033 in terms of value the market will surpass US$ 2,819.2 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Clinical Trial Supplies Market, 2023 to 2033 report help you?
In summary, our 420+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Clinical Trial Supplies Market, 2023 to 2033, with forecasts for location, type, services, therapeutic areas, phase, and end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 19 key national markets – See forecasts for the Clinical Trial Supplies Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 30 of the major companies involved in the Clinical Trial Supplies Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Clinical Trial Supplies Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Clinical Trial Supplies Market Report 2023-2033: Forecasts by Location (Offshore Clinical Site, Domestic Clinical Site), by Type (Small Molecule Products, Biologic Products, Medical Devices), by Services (Manufacturing (IMPs and INDs, Placebos, Assays and Test Kits, Others), Logistics & Distribution (Cold Chain Distribution, Non-cold Chain), Storage & Retention, Packaging and Labelling, Comparator Sourcing, Other), by Therapeutic Areas (Oncology, CNS and Mental Disorders, Cardiovascular Disease (CVD), Infectious Disease, Immunology Disease, Blood Disorders, Metabolic Disorders, Digestive Disorders, Other), by Phase (Phase-I, Phase-II, Phase-III, Phase-IV), by End-user (Contract Research Organisations, Pharmaceutical and Biotechnology Companies, Medical Device Companies, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Clinical Trial Supplies Market Report 2023-2033

    Related reports

    Download sample pages

    Complete the form below to download your free sample pages for Clinical Trial Supplies Market Report 2023-2033

      Connect with us

      Visiongain Pharma

      Visiongain Pharma

      Visiongain Pharma

      Latest Pharma news

      Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

      The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

      23 April 2024

      READ
      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ
      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ
      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ